dromlakhani Target preoperative HbA1c <8% and blood glucose 100–180 mg/dL before elective surgery
STEP 1 — Gather Information
Confirm diabetes diagnosis, elective surgery schedule, obtain most recent HbA1c and point-of-care glucose; assess conditions that may affect HbA1c reliability (anemia, hemoglobinopathies, chronic renal failure, alcoholism, drugs, large glucose variability).
STEP 2 — Rule In / Rule Out
Is it reasonable to allow time for interventions targeting HbA1c <8%? If yes, proceed to HbA1c optimization pathway; if no, proceed to blood glucose target pathway.
STEP 3 — Classify or Stratify
If HbA1c pathway: classify HbA1c as <8% (target met) or ≥8% (needs intervention). If BG pathway: classify recent glucose as within 100–180 mg/dL (target met) or outside this range (needs intervention).
STEP 4 — Decide
If target met, proceed with routine preoperative care; if not met, intensify glucose-lowering therapy (e.g., adjust metformin, initiate insulin) and recheck HbA1c or glucose in 1–2 weeks.
Clinical Guardrails / Mimics / Pitfalls
Do not rely on HbA1c if conditions affecting erythrocyte turnover (anemia, hemoglobinopathies, renal failure) are present; avoid delaying urgent surgery for HbA1c optimization; do not administer preoperative caloric carbohydrate-containing fluids; avoid sliding scale insulin alone for persistent hyperglycemia ≥180 mg/dL.
Concrete Clinical Example
A 60‑year‑old with type 2 diabetes scheduled for elective knee arthroplasty in 3 weeks has HbA1c 8.4% and fasting glucose 135 mg/dL. Since time permits, aim for HbA1c <8% via metformin uptitration; after 3 weeks HbA1c 7.7% and glucose 120 mg/dL, proceed to surgery.
Source: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, https://doi.org/10.1210/clinem/dgac278
TODO: consider adding scripts/calc.py for the endo-preoperative-hba1c-bg-target-elective-surgery calculator